Evidence map›Paper›PMID 40606239›Full record

ArticleActa informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH2025

Nevus Spilus: A Review of Laser-Based Therapeutic Approaches.

Jamal Alqahtani

Abstract read
In one paragraph

Article in Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jamal AlqahtaniDepartment of Dermatology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Eastern Province, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Nevus spilus (NS) is a congenital melanocytic nevus with specific clinical characteristics. The condition generally appears in the first year of life and shows no gender preference while affecting individuals with lighter skin tones. It has a predilection for lower limbs and trunk areas the NS lesions consist of tiny heavily pigmented papules and macules accumulated on a well-bordered, lighter brown macular backdrop, comparable to a café-au-lait macule, frequently along Blaschko lines. The type of nevus has been reported as a blue nevus, centrofacial lentiginosis, nevus sebaceous, and bilateral nevus of Ito. Objective: To highlight laser options for nevus spilus. Methods: A review of various laser-based treatment modalities was conducted, focusing on their application in NS. The lasers included Q-switched ruby (QSRL), alexandrite (QSAL), Nd:YAG 532 and 1064 nm, carbon dioxide (CO2), intense pulsed light (IPL), and pulsed dye laser (PDL). Results and Discussion: The laser modalities have shown varying degrees of success in improving the appearance of NS lesions. The QSRL, QSAL and QSNYL lasers are commonly used because they are specific for melanin. Ablative lasers like CO2 and broad-spectrum devices like IPL and PDL have also been employed, each offering different advantages depending on lesion characteristics and treatment goals. Conclusion: Regular monitoring for suspicious malignant degeneration should be done and if any signs of melanoma are present, histological examination is warranted. While no treatment is usually necessary, surgery has been proposed to eliminate the risk of melanoma. Aside from surgical management, various lasers have been tried to treat NS with varied success. QSRL, QSAL, QSNYL 532, and 1064 nm, CO2, IPL and PDL have all been demonstrated to improve NS.

Indexed as

Laser treatmentManagement of NSNevus spilus

Identifiers

PMID40606239
PMCPMC12212278

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.